Detalles de la búsqueda
1.
Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator.
Respir Res
; 21(Suppl 1): 211, 2020 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907576
2.
Abediterol, a novel long-acting ß2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD.
BMC Pulm Med
; 16(1): 102, 2016 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27439370
3.
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting ß2-adrenergic agonist, in asthma; a Phase II, randomized study.
BMC Pulm Med
; 14: 176, 2014 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25398689
4.
Rethinking the use of urine dipstick for early diagnosis of Type 2 diabetes mellitus.
Diabetes Res Clin Pract
; 184: 109222, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35114298
5.
Screening for type 2 diabetes and hypertension in seafarers' medical examinations.
Int Marit Health
; 73(2): 64-72, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35781681
6.
Call for the National Boards of Health and the Maritime Administrations to introduce valid screening for type 2 diabetes at the maritime medical examinations.
Int Marit Health
; 74(1): 70-71, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36974495
7.
Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study.
Pharmacol Res Perspect
; 5(5)2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28971615
Resultados
1 -
7
de 7
1
Próxima >
>>